Table 2.
Date | Echocardiographic data | Dialysis and cardiac medication | Symptoms |
---|---|---|---|
2014 | EF 41%, PAP 60 with severe TR |
|
|
2015 | EF 60%, PAP 77, moderate– to–severe TR | Frequent HHD, 6 × 2 h with 20 L | Development of significant ascites, significant SOB |
2016 | EF 55–65%, PAP 21, mild TR | Frequent HHD, 6 × 2 h 45 min, 25 L, reintroduction of ARB | Reduction in ascites, improvement in SOB |
2019 | EF 60–65%, normal PAP, trivial TR | Frequent HHD, 6 × 2.5 h. ARB and calcium channel antagonist | No ascites, no SOB, improved exercise tolerance |
PAP, pulmonary artery pressure; TR, tricuspid regurgitation; SOB, shortness of breath.